January 23, 2018
U.S. FDA OK’s Baxter’s ready-to-use cardiovascular medication Bivalirudin
Baxter International has announced the U.S. Food and Drug Administration (FDA) approval of Bivalirudin in 0.9 percent Sodium Chloride Injection…